APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antidiabetic Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antidiabetic Drugs Industry Growth and Trends Forecast to 2032

27 December 2025103 pages

Choose your research edition.

Industry ResearchAntidiabetic Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidiabetic Drugs Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Antidiabetic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidiabetic Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidiabetic Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Antidiabetic Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antidiabetic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antidiabetic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antidiabetic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antidiabetic Drugs include Takeda, Sanofi, Novartis, Merck, Eli Lilly, Pfizer, Bayer, AstraZeneca and Novo Nordisk, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antidiabetic Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antidiabetic Drugs market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antidiabetic Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antidiabetic Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antidiabetic Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antidiabetic Drugs Market by Company

Takeda

Sanofi

Novartis

Merck

Eli Lilly

Pfizer

Bayer

AstraZeneca

Novo Nordisk

Boehringer Ingelheim

Antidiabetic Drugs Segment by Type

Oral Drugs

Injectable Drugs

Antidiabetic Drugs Segment by Application

Type 1 Diabetes

Type 2 Diabetes

Gestational Diabetes Mellitus

Others

Antidiabetic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidiabetic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidiabetic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidiabetic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antidiabetic Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antidiabetic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Drugs Table 2. Major Company of Injectable Drugs Table 3. Global Antidiabetic Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Antidiabetic Drugs Sales by Type (2021-2026) & (W Units) Table 5. Global Antidiabetic Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Antidiabetic Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Antidiabetic Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Antidiabetic Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Antidiabetic Drugs Sales by Type (2027-2032) & (W Units) Table 10. Global Antidiabetic Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Antidiabetic Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Antidiabetic Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Antidiabetic Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Antidiabetic Drugs Sales by Type (2021-2026) & (W Units) Table 15. North America Antidiabetic Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Antidiabetic Drugs Sales by Type (2021-2026) & (W Units) Table 17. Europe Antidiabetic Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Antidiabetic Drugs Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Antidiabetic Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Antidiabetic Drugs Sales by Type (2021-2026) & (W Units) Table 21. Latin America Antidiabetic Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Antidiabetic Drugs Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Antidiabetic Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Antidiabetic Drugs Industry Trends Table 25. Antidiabetic Drugs Industry Drivers Table 26. Antidiabetic Drugs Industry Opportunities and Challenges Table 27. Antidiabetic Drugs Industry Restraints Table 28. Global Antidiabetic Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Antidiabetic Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Antidiabetic Drugs Sales by Company (2021-2026) & (W Units) Table 31. Global Antidiabetic Drugs Sales Share by Company (2021-2026) Table 32. Global Antidiabetic Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Antidiabetic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Antidiabetic Drugs Major Company Production Sites and Headquarters Table 35. Global Antidiabetic Drugs Company, Product Type & Application Table 36. Global Antidiabetic Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Antidiabetic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Antidiabetic Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Antidiabetic Drugs Sales by Region (2021-2026) & (W Units) Table 41. Global Antidiabetic Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Antidiabetic Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Antidiabetic Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Antidiabetic Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Antidiabetic Drugs Sales by Region (2027-2032) & (W Units) Table 46. Global Antidiabetic Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Antidiabetic Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Antidiabetic Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Antidiabetic Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Antidiabetic Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Antidiabetic Drugs Sales by Application (2021-2026) & (W Units) Table 52. Global Antidiabetic Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Antidiabetic Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Antidiabetic Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Antidiabetic Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Antidiabetic Drugs Sales by Application (2027-2032) & (W Units) Table 57. Global Antidiabetic Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Antidiabetic Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Antidiabetic Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Antidiabetic Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Antidiabetic Drugs Sales by Application (2021-2026) & (W Units) Table 62. North America Antidiabetic Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Antidiabetic Drugs Sales by Application (2021-2026) & (W Units) Table 64. Europe Antidiabetic Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Antidiabetic Drugs Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Antidiabetic Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Antidiabetic Drugs Sales by Application (2021-2026) & (W Units) Table 68. Latin America Antidiabetic Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Antidiabetic Drugs Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Antidiabetic Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda Antidiabetic Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Takeda Antidiabetic Drugs Product Portfolio Table 75. Takeda Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Antidiabetic Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sanofi Antidiabetic Drugs Product Portfolio Table 80. Sanofi Recent Development Table 81. Novartis Company Information Table 82. Novartis Business Overview Table 83. Novartis Antidiabetic Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Novartis Antidiabetic Drugs Product Portfolio Table 85. Novartis Recent Development Table 86. Merck Company Information Table 87. Merck Business Overview Table 88. Merck Antidiabetic Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Merck Antidiabetic Drugs Product Portfolio Table 90. Merck Recent Development Table 91. Eli Lilly Company Information Table 92. Eli Lilly Business Overview Table 93. Eli Lilly Antidiabetic Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Eli Lilly Antidiabetic Drugs Product Portfolio Table 95. Eli Lilly Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Antidiabetic Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Pfizer Antidiabetic Drugs Product Portfolio Table 100. Pfizer Recent Development Table 101. Bayer Company Information Table 102. Bayer Business Overview Table 103. Bayer Antidiabetic Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Bayer Antidiabetic Drugs Product Portfolio Table 105. Bayer Recent Development Table 106. AstraZeneca Company Information Table 107. AstraZeneca Business Overview Table 108. AstraZeneca Antidiabetic Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. AstraZeneca Antidiabetic Drugs Product Portfolio Table 110. AstraZeneca Recent Development Table 111. Novo Nordisk Company Information Table 112. Novo Nordisk Business Overview Table 113. Novo Nordisk Antidiabetic Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Novo Nordisk Antidiabetic Drugs Product Portfolio Table 115. Novo Nordisk Recent Development Table 116. Boehringer Ingelheim Company Information Table 117. Boehringer Ingelheim Business Overview Table 118. Boehringer Ingelheim Antidiabetic Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Boehringer Ingelheim Antidiabetic Drugs Product Portfolio Table 120. Boehringer Ingelheim Recent Development Table 121. North America Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 122. North America Antidiabetic Drugs Sales by Country (2021-2026) & (W Units) Table 123. North America Antidiabetic Drugs Sales Market Share by Country (2021-2026) Table 124. North America Antidiabetic Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 125. North America Antidiabetic Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. North America Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Antidiabetic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Antidiabetic Drugs Market Share by Country (2021-2026) Table 129. North America Antidiabetic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Antidiabetic Drugs Market Share Forecast by Country (2027-2032) Table 131. Europe Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 132. Europe Antidiabetic Drugs Sales by Country (2021-2026) & (W Units) Table 133. Europe Antidiabetic Drugs Sales Market Share by Country (2021-2026) Table 134. Europe Antidiabetic Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 135. Europe Antidiabetic Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Antidiabetic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Antidiabetic Drugs Market Share by Country (2021-2026) Table 139. Europe Antidiabetic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Antidiabetic Drugs Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Antidiabetic Drugs Sales by Country (2021-2026) & (W Units) Table 143. Asia-Pacific Antidiabetic Drugs Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Antidiabetic Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 145. Asia-Pacific Antidiabetic Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Antidiabetic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Antidiabetic Drugs Market Share by Country (2021-2026) Table 149. Asia-Pacific Antidiabetic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Antidiabetic Drugs Market Share Forecast by Country (2027-2032) Table 151. Latin America Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 152. Latin America Antidiabetic Drugs Sales by Country (2021-2026) & (W Units) Table 153. Latin America Antidiabetic Drugs Sales Market Share by Country (2021-2026) Table 154. Latin America Antidiabetic Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 155. Latin America Antidiabetic Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Antidiabetic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Antidiabetic Drugs Market Share by Country (2021-2026) Table 159. Latin America Antidiabetic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Antidiabetic Drugs Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Antidiabetic Drugs Sales by Country (2021-2026) & (W Units) Table 163. Middle East and Africa Antidiabetic Drugs Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Antidiabetic Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 165. Middle East and Africa Antidiabetic Drugs Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Antidiabetic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Antidiabetic Drugs Market Share by Country (2021-2026) Table 169. Middle East and Africa Antidiabetic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Antidiabetic Drugs Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Antidiabetic Drugs Distributors List Table 174. Antidiabetic Drugs Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Antidiabetic Drugs Image Figure 2. Global Antidiabetic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antidiabetic Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Antidiabetic Drugs Sales (2021-2032) & (W Units) Figure 5. Oral Drugs Image Figure 6. Global Oral Drugs Sales YoY Growth (2021-2032) & (W Units) Figure 7. Injectable Drugs Image Figure 8. Global Injectable Drugs Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Antidiabetic Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Antidiabetic Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Antidiabetic Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Antidiabetic Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Antidiabetic Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Antidiabetic Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Antidiabetic Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Antidiabetic Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Antidiabetic Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Antidiabetic Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Antidiabetic Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Antidiabetic Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Antidiabetic Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Type 1 Diabetes Image Figure 24. Global Type 1 Diabetes Sales YoY Growth (2021-2032) & (W Units) Figure 25. Type 2 Diabetes Image Figure 26. Global Type 2 Diabetes Sales YoY Growth (2021-2032) & (W Units) Figure 27. Gestational Diabetes Mellitus Image Figure 28. Global Gestational Diabetes Mellitus Sales YoY Growth (2021-2032) & (W Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Antidiabetic Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Antidiabetic Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Antidiabetic Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Antidiabetic Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Antidiabetic Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Antidiabetic Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Antidiabetic Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Antidiabetic Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Antidiabetic Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Antidiabetic Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Antidiabetic Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Antidiabetic Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Antidiabetic Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Antidiabetic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Antidiabetic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Antidiabetic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Antidiabetic Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Antidiabetic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Antidiabetic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Antidiabetic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Antidiabetic Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Antidiabetic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Antidiabetic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Antidiabetic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Antidiabetic Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Antidiabetic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Antidiabetic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Antidiabetic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Antidiabetic Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Antidiabetic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Antidiabetic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Antidiabetic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Antidiabetic Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Antidiabetic Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Drugs
  • Injectable Drugs
Applications
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes Mellitus
  • Others
Companies covered
  • Takeda
  • Sanofi
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • Bayer
  • AstraZeneca
  • Novo Nordisk
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antidiabetic Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antidiabetic Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antidiabetic Drugs Market by Type
  6. 1.3.1 Oral Drugs
  7. 1.3.2 Injectable Drugs
  8. 1.4 Global Antidiabetic Drugs Market Size by Type
  9. 1.4.1 Global Antidiabetic Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Antidiabetic Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Antidiabetic Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Antidiabetic Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Antidiabetic Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Antidiabetic Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Antidiabetic Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Antidiabetic Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antidiabetic Drugs Industry Trends
  2. 2.2 Antidiabetic Drugs Industry Drivers
  3. 2.3 Antidiabetic Drugs Industry Opportunities and Challenges
  4. 2.4 Antidiabetic Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antidiabetic Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Antidiabetic Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Antidiabetic Drugs Price (2021-2026)
  4. 3.4 Global Antidiabetic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antidiabetic Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Antidiabetic Drugs Company, Product Type & Application
  7. 3.7 Global Antidiabetic Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antidiabetic Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antidiabetic Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antidiabetic Drugs Tier 1, Tier 2, and Tier 3
4 Antidiabetic Drugs Regional Status and Outlook
  1. 4.1 Global Antidiabetic Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antidiabetic Drugs Historic Market Size by Region
  3. 4.2.1 Global Antidiabetic Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antidiabetic Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antidiabetic Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antidiabetic Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Antidiabetic Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antidiabetic Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antidiabetic Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antidiabetic Drugs by Application
  1. 5.1 Antidiabetic Drugs Market by Application
  2. 5.1.1 Type 1 Diabetes
  3. 5.1.2 Type 2 Diabetes
  4. 5.1.3 Gestational Diabetes Mellitus
  5. 5.1.4 Others
  6. 5.2 Global Antidiabetic Drugs Market Size by Application
  7. 5.2.1 Global Antidiabetic Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Antidiabetic Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Antidiabetic Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Antidiabetic Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Antidiabetic Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Antidiabetic Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Antidiabetic Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Antidiabetic Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Antidiabetic Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Antidiabetic Drugs Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Antidiabetic Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Antidiabetic Drugs Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Antidiabetic Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Antidiabetic Drugs Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Antidiabetic Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Antidiabetic Drugs Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Eli Lilly
  26. 6.5.1 Eli Lilly Company Information
  27. 6.5.2 Eli Lilly Business Overview
  28. 6.5.3 Eli Lilly Antidiabetic Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly Antidiabetic Drugs Product Portfolio
  30. 6.5.5 Eli Lilly Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Antidiabetic Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Antidiabetic Drugs Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Bayer
  38. 6.7.1 Bayer Company Information
  39. 6.7.2 Bayer Business Overview
  40. 6.7.3 Bayer Antidiabetic Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bayer Antidiabetic Drugs Product Portfolio
  42. 6.7.5 Bayer Recent Developments
  43. 6.8 AstraZeneca
  44. 6.8.1 AstraZeneca Company Information
  45. 6.8.2 AstraZeneca Business Overview
  46. 6.8.3 AstraZeneca Antidiabetic Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AstraZeneca Antidiabetic Drugs Product Portfolio
  48. 6.8.5 AstraZeneca Recent Developments
  49. 6.9 Novo Nordisk
  50. 6.9.1 Novo Nordisk Company Information
  51. 6.9.2 Novo Nordisk Business Overview
  52. 6.9.3 Novo Nordisk Antidiabetic Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novo Nordisk Antidiabetic Drugs Product Portfolio
  54. 6.9.5 Novo Nordisk Recent Developments
  55. 6.10 Boehringer Ingelheim
  56. 6.10.1 Boehringer Ingelheim Company Information
  57. 6.10.2 Boehringer Ingelheim Business Overview
  58. 6.10.3 Boehringer Ingelheim Antidiabetic Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Boehringer Ingelheim Antidiabetic Drugs Product Portfolio
  60. 6.10.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Antidiabetic Drugs Sales by Country
  2. 7.1.1 North America Antidiabetic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antidiabetic Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Antidiabetic Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antidiabetic Drugs Market Size by Country
  6. 7.2.1 North America Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antidiabetic Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Antidiabetic Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antidiabetic Drugs Sales by Country
  2. 8.1.1 Europe Antidiabetic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antidiabetic Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Antidiabetic Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antidiabetic Drugs Market Size by Country
  6. 8.2.1 Europe Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antidiabetic Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antidiabetic Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antidiabetic Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Antidiabetic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antidiabetic Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antidiabetic Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antidiabetic Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antidiabetic Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antidiabetic Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antidiabetic Drugs Sales by Country
  2. 10.1.1 South America Antidiabetic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antidiabetic Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Antidiabetic Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antidiabetic Drugs Market Size by Country
  6. 10.2.1 South America Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antidiabetic Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Antidiabetic Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antidiabetic Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Antidiabetic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antidiabetic Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antidiabetic Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antidiabetic Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Antidiabetic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antidiabetic Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antidiabetic Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antidiabetic Drugs Value Chain Analysis
  2. 12.1.1 Antidiabetic Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antidiabetic Drugs Production Mode & Process
  7. 12.2 Antidiabetic Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antidiabetic Drugs Distributors
  10. 12.2.3 Antidiabetic Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst